New Ventures Executive
Alina holds a Masters degree in Chemistry from Lomonosov Moscow State University, a PhD in Biochemistry from the University of Oxford and an MBA from Quantic School of Business and Technology. Alina is an experienced entrepreneur and translational professional, having co-founded EnzBond Ltd as a first student-led Oxford University spinout in life sciences. During her career she has led and assisted with securing various Seed and Series A financial rounds. Alina joined Cancer Research Horizon’s Commercial Partnerships in 2019 and in her current new ventures role is responsible for overseeing the operations of our Cancer Research Horizons’ Seed Fund alongside creating, developing and securing financing for new startup propositions.